Shopping Cart 0
Cart Subtotal
AED 0

Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Qiagen NV (QIA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Qiagen NV (Qiagen) is a provider of molecular testing solutions. The company's sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue; assay technologies to identify the genetic information of a pathogen in a tumor; bioinformatics solutions to analyze and interpret genomic data; and solutions to automate the use of consumables into efficient molecular testing workflows. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical and biotechnology and life sciences research markets. The company offers its products through subsidiaries and a network of independent distributors. It has operations in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Qiagen is headquartered in Venlo, the Netherlands.

Qiagen NV Key Recent Developments

Mar 08,2019 Qiagen parthers with Tecan to improve tuberculosis test

Feb 19,2019 Qiagen, Ares Genetics partner on tests for antibiotic-resistant pathogens

Feb 04,2019 QIAGEN Informatics Solutions Chosen to Support Genomics Englands Bold Five Million Genomes in Five Years Project

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Qiagen NV-Key Facts

Qiagen NV-Key Employees

Qiagen NV-Key Employee Biographies

Qiagen NV-Major Products and Services

Qiagen NV-History

Qiagen NV-Company Statement

Qiagen NV-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Qiagen NV-Business Description

Product Category: Consumables and Related Revenues

Overview

Performance

Product Category: Instrumentation

Overview

Performance

Geographical Segment: Americas

Performance

Geographical Segment: Asia Pacific and Rest of World

Performance

Geographical Segment: Europe, Middle East and Africa

Performance

R&D Overview

Qiagen NV-SWOT Analysis

SWOT Analysis-Overview

Qiagen NV-Strengths

Qiagen NV-Weaknesses

Qiagen NV-Opportunities

Qiagen NV-Threats

Qiagen NV-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Qiagen NV, Medical Equipment, Deals By Year, 2013 to YTD 2019

Qiagen NV, Medical Equipment, Deals By Type, 2013 to YTD 2019

Qiagen NV, Recent Deals Summary

Section 5-Company's Recent Developments

Mar 08, 2019: Qiagen partners with Tecan to improve tuberculosis test

Mar 08, 2019: Qiagen parthers with Tecan to improve tuberculosis test

Feb 19, 2019: Qiagen, Ares Genetics partner on tests for antibiotic-resistant pathogens

Feb 04, 2019: QIAGEN Informatics Solutions Chosen to Support Genomics Englands Bold Five Million Genomes in Five Years Project

Feb 04, 2019: QIAGEN informatics solutions chosen to support Genomics England's bold five million genomes in five years project

Feb 04, 2019: QIAGEN announces results for fourth quarter and full-year 2018

Jan 16, 2019: QIAGEN receives first companion diagnostic approval in Japan

Jan 07, 2019: QIAGEN to Develop QuantiFERON-TB Access as a New Test for Low-Resource, High-Burden Regions in Global Fight Against TB

Jan 07, 2019: QIAGEN unveils plans for next-generation digital PCR systems

Jan 07, 2019: QIAGEN launches QIAcube Connect-next-generation automation for sample processing in research labs

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Qiagen NV, Performance Chart (2014-2018)

Qiagen NV, Ratio Charts

Qiagen NV, Medical Equipment, Deals By Year, 2013 to YTD 2019

Qiagen NV, Medical Equipment, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Qiagen NV, Key Facts

Qiagen NV, Key Employees

Qiagen NV, Key Employee Biographies

Qiagen NV, Major Products and Services

Qiagen NV, History

Qiagen NV, Subsidiaries

Qiagen NV, Joint Venture

Qiagen NV, Key Competitors

Qiagen NV, Ratios based on current share price

Qiagen NV, Annual Ratios

Qiagen NV, Annual Ratios (Cont...1)

Qiagen NV, Annual Ratios (Cont...2)

Qiagen NV, Interim Ratios

Qiagen NV, Medical Equipment, Deals By Year, 2013 to YTD 2019

Qiagen NV, Medical Equipment, Deals By Type, 2013 to YTD 2019

Qiagen NV, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Qiagen NV, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Roche Diagnostics International Ltd

Expedeon AG

Promega Corp

MilliporeSigma

Hologic Inc

Macherey-Nagel GmbH & Co.

EMD Millipore Corp

Qiagen NV (QIA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Qiagen NV (Qiagen) is a provider of molecular testing solutions. The company's sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue; assay technologies to identify the genetic information of a pathogen in a tumor; bioinformatics solutions to analyze and interpret genomic data; and solutions to automate the use of consumables into efficient molecular testing workflows. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical and biotechnology and life sciences research markets. The company offers its products through subsidiaries and a network of independent distributors. It has operations in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Qiagen is headquartered in Venlo, the Netherlands.

Qiagen NV Key Recent Developments

Mar 08,2019 Qiagen parthers with Tecan to improve tuberculosis test

Feb 19,2019 Qiagen, Ares Genetics partner on tests for antibiotic-resistant pathogens

Feb 04,2019 QIAGEN Informatics Solutions Chosen to Support Genomics Englands Bold Five Million Genomes in Five Years Project

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Qiagen NV-Key Facts

Qiagen NV-Key Employees

Qiagen NV-Key Employee Biographies

Qiagen NV-Major Products and Services

Qiagen NV-History

Qiagen NV-Company Statement

Qiagen NV-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Qiagen NV-Business Description

Product Category: Consumables and Related Revenues

Overview

Performance

Product Category: Instrumentation

Overview

Performance

Geographical Segment: Americas

Performance

Geographical Segment: Asia Pacific and Rest of World

Performance

Geographical Segment: Europe, Middle East and Africa

Performance

R&D Overview

Qiagen NV-SWOT Analysis

SWOT Analysis-Overview

Qiagen NV-Strengths

Qiagen NV-Weaknesses

Qiagen NV-Opportunities

Qiagen NV-Threats

Qiagen NV-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Qiagen NV, Medical Equipment, Deals By Year, 2013 to YTD 2019

Qiagen NV, Medical Equipment, Deals By Type, 2013 to YTD 2019

Qiagen NV, Recent Deals Summary

Section 5-Company's Recent Developments

Mar 08, 2019: Qiagen partners with Tecan to improve tuberculosis test

Mar 08, 2019: Qiagen parthers with Tecan to improve tuberculosis test

Feb 19, 2019: Qiagen, Ares Genetics partner on tests for antibiotic-resistant pathogens

Feb 04, 2019: QIAGEN Informatics Solutions Chosen to Support Genomics Englands Bold Five Million Genomes in Five Years Project

Feb 04, 2019: QIAGEN informatics solutions chosen to support Genomics England's bold five million genomes in five years project

Feb 04, 2019: QIAGEN announces results for fourth quarter and full-year 2018

Jan 16, 2019: QIAGEN receives first companion diagnostic approval in Japan

Jan 07, 2019: QIAGEN to Develop QuantiFERON-TB Access as a New Test for Low-Resource, High-Burden Regions in Global Fight Against TB

Jan 07, 2019: QIAGEN unveils plans for next-generation digital PCR systems

Jan 07, 2019: QIAGEN launches QIAcube Connect-next-generation automation for sample processing in research labs

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Qiagen NV, Performance Chart (2014-2018)

Qiagen NV, Ratio Charts

Qiagen NV, Medical Equipment, Deals By Year, 2013 to YTD 2019

Qiagen NV, Medical Equipment, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Qiagen NV, Key Facts

Qiagen NV, Key Employees

Qiagen NV, Key Employee Biographies

Qiagen NV, Major Products and Services

Qiagen NV, History

Qiagen NV, Subsidiaries

Qiagen NV, Joint Venture

Qiagen NV, Key Competitors

Qiagen NV, Ratios based on current share price

Qiagen NV, Annual Ratios

Qiagen NV, Annual Ratios (Cont...1)

Qiagen NV, Annual Ratios (Cont...2)

Qiagen NV, Interim Ratios

Qiagen NV, Medical Equipment, Deals By Year, 2013 to YTD 2019

Qiagen NV, Medical Equipment, Deals By Type, 2013 to YTD 2019

Qiagen NV, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Qiagen NV, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Roche Diagnostics International Ltd

Expedeon AG

Promega Corp

MilliporeSigma

Hologic Inc

Macherey-Nagel GmbH & Co.

EMD Millipore Corp